Review
doi: 10.1016/s0033-8389(05)70149-4.
Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy
Affiliations
- PMID: 10664666
- DOI: 10.1016/s0033-8389(05)70149-4
Item in Clipboard
Review
Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy
Radiol Clin North Am.
2000 Jan.
Abstract
Refinement in the local staging and risk assessment for prostate cancer patients utilizing clinical parameters is ongoing. DRE, tumor grade, and PSA provide some useful information for risk assessment in individual patients. More recent studies using percent free PSA levels and systematic biopsy results have added additional staging information and may play a more significant role in the future in risk assessment. This information should supplement additional imaging tests in the management of these patients.
Similar articles
-
Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4. Urology. 2003. PMID: 12670560
-
Use of percent free prostate-specific antigen density to improve the specificity for detecting prostate cancer in patients with normal rectal examinations and intermediate prostate-specific antigen levels.Urol Int. 2003;70(1):36-41. doi: 10.1159/000067700. Urol Int. 2003. PMID: 12566813
-
Prostate cancer screening in Tyrol, Austria: experience and results.Eur Urol. 1999;35(5-6):523-38. doi: 10.1159/000019893. Eur Urol. 1999. PMID: 10325519
-
Incidental carcinoma of the prostate.Semin Surg Oncol. 1995 Jan-Feb;11(1):36-45. doi: 10.1002/ssu.2980110106. Semin Surg Oncol. 1995. PMID: 7538693 Review.
-
Prostate-specific antigen in screening of prostate cancer.J Clin Lab Anal. 1994;8(5):323-6. doi: 10.1002/jcla.1860080511. J Clin Lab Anal. 1994. PMID: 7528795 Review.
Cited by
-
Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Quant Imaging Med Surg. 2013 Apr;3(2):100-12. doi: 10.3978/j.issn.2223-4292.2013.03.03. Quant Imaging Med Surg. 2013. PMID: 23630657 Free PMC article.
-
Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.Mol Cancer Ther. 2009 Mar;8(3):509-20. doi: 10.1158/1535-7163.MCT-08-0693. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276166 Free PMC article.
-
[Capillary electrophoresis coupled to mass spectrometry for proteome analysis. An innovative diagnostic method for prostate and bladder cancer].Urologe A. 2007 Jul;46(7):733-9. doi: 10.1007/s00120-007-1302-0. Urologe A. 2007. PMID: 17318473 Review. German.
-
Biomarkers for prostate cancer.World J Urol. 2007 Dec;25(6):557-62. doi: 10.1007/s00345-007-0203-6. Epub 2007 Aug 10. World J Urol. 2007. PMID: 17690889 Review.
-
Cadherin switching and activation of beta-catenin signaling underlie proinvasive actions of calcitonin-calcitonin receptor axis in prostate cancer.J Biol Chem. 2009 Jan 9;284(2):1018-30. doi: 10.1074/jbc.M807823200. Epub 2008 Nov 9. J Biol Chem. 2009. PMID: 19001380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
